Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorHendrickx, Stijn
dc.contributor.authorUğur, Duygu Yeniceli
dc.contributor.authorYılmaz, Işıl Tan
dc.contributor.authorŞener, Erol
dc.contributor.authorVan Schepdael, Ann
dc.contributor.authorAdams, Erwin
dc.contributor.authorCabooter, Deirdre
dc.date.accessioned2019-10-19T14:02:42Z
dc.date.available2019-10-19T14:02:42Z
dc.date.issued2017
dc.identifier.issn0039-9140
dc.identifier.issn1873-3573
dc.identifier.urihttps://dx.doi.org/10.1016/j.talanta.2016.09.053
dc.identifier.urihttps://hdl.handle.net/11421/12348
dc.descriptionWOS: 000389088700037en_US
dc.descriptionPubMed ID: 27837829en_US
dc.description.abstractA specific and sensitive capillary liquid chromatography-ultraviolet detection (cap-LC-UV) method in combination with a micro-extraction by packed sorbent (MEPS) sample clean-up procedure has been developed and validated for the simultaneous analysis of chlorpromazine, olanzapine and their flavin-containing monooxygenase (FMO) mediated N-oxides in rat brain microdialysates. Chromatographic separation was obtained on an Acclaim Pepmap RP C18 column with an ID of 300 mu m. An injection volume of 20 L was used to inject the largely aqueous samples and was shown to have no influence on the obtained peak shape of the compounds of interest. Optimal conditions for MEPS extraction were obtained on a mixed-mode M1 (80% C8, 20% SCX) cartridge after diluting microdialysate samples with phosphate buffer pH 2.5 (1:3 v/v). The method was validated and lower limits of quantification (LLOQ) were determined at 0.5 nM for all compounds. Linearity was demonstrated between the LLOQ and 1 mu M for all compounds (R-2 > 0.995). MEPS recoveries were between 92% and 98%, with intra- and interday variabilities below 15%. The applicability of the developed method was successfully demonstrated by analysing rat brain microdialysates. The capillary LC-UV method in combination with MEPS sample treatment provides a simple, sensitive method to quantify all compounds of interest in 45 min and can be applied for routine therapeutic monitoring and pharmacokinetic studies of olanzapine, chlorpromazine and their respective N-oxides.en_US
dc.description.sponsorshipScientific and Technical Research Council of Turkey (TUBITAK) [113S036]; Research Foundation Flanders (FWO) [VS.054.13N.LC]en_US
dc.description.sponsorshipThis work was supported by the Scientific and Technical Research Council of Turkey (TUBITAK) (Project No. 113S036); and the Research Foundation Flanders (FWO) (Project No. VS.054.13N.LC).en_US
dc.language.isoengen_US
dc.publisherElsevier Science BVen_US
dc.relation.isversionof10.1016/j.talanta.2016.09.053en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOlanzapineen_US
dc.subjectChlorpromazineen_US
dc.subjectFmoen_US
dc.subjectCapillary Lcen_US
dc.subjectMicrodialysisen_US
dc.subjectMepsen_US
dc.titleA sensitive capillary LC-UV method for the simultaneous analysis of olanzapine, chlorpromazine and their FMO-mediated N-oxidation products in brain microdialysatesen_US
dc.typearticleen_US
dc.relation.journalTalantaen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Analitik Kimya Anabilim Dalıen_US
dc.identifier.volume162en_US
dc.identifier.startpage268en_US
dc.identifier.endpage277en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster